| 摘要 |
<p><P>PROBLEM TO BE SOLVED: To provide a combination useful for the prevention, delay of progression or treatment of conditions mediated by dipeptidylpeptidase-IV inhibitor (DPP-IV), particularly diabetes, further particularly type 2 diabetes, impairment of glucose tolerance (IGT), conditions of impaired fasting plasma glucose, metabolic acidosis, ketosis, arthritis, obesity and osteoporosis. <P>SOLUTION: The combination includes a DPP-IV inhibitor and at least one further antidiabetic combination. <P>COPYRIGHT: (C)2011,JPO&INPIT</p> |
